Data Completeness
2021 - Completeness | |
---|---|
N datasets | 5* |
N observations | 17026 |
Age | 100.0% |
Sex | 100.0% |
HIV status | 99.4% |
Past treatment | 72.9% |
AFB positive at baseline | 89.1% |
Culture converted at month 6 | 65.8% |
Culture converted at month 2 | 21.3% |
Outcome | 100.0% |
Relapse | 1.5% |
Lzd resistant at baseline | 1.4% |
Mfx resistant at baseline | 4.2% |
LfxÌýresistant at baseline | 4.8% |
OfxÌýresistant at baseline | 6.1% |
CfxÌýresistant at baseline | 0.0% |
BdqÌýresistant at baseline | 0.9% |
Ìý*two datasets from South Africa are counted as one Original Data Curator: Prof Greg Fox, The University of Sydney, Australia
Individual Datasets
Author | Overall | Belarus | Georgia | Moldova | Somalia | South Africa |
---|---|---|---|---|---|---|
WHO Region | Ìý | European | European | Eurropean | Eastern Mediteranean | African |
Type of Study | Ìý | Unpublished | Unpublished | Unpublished | Unpublished | Unpublished |
N observations | 17026 | 99 | 151 | 132 | 25 | 16619 |
AgeÌý≥ 18 years | 95.2% | 98.0% | 97.4% | 100.0% | 68.0% | 95.2% |
Sex, male | 58.7% | 59.6% | 78.1% | 77.3% | 64.0% | 58.3% |
HIV positive | 67.5% | 9.1% | 4.0% | 14.4%Ìý | - | 68.9% |
Recieved previous TB treatment | 44.5% | 59.6% | 73.5% | 82.6% | 44.0% | 43.8% |
Previous treatment: FLD | 1.2% | 41.4% | 41.1% | 73.5% | 48.0% | - |
Previous treatment: SLD | 1.4% | 47.5% | 65.6% | 73.5% | - | - |
AFB positive | 37.7% | 49.5% | 68.2% | 58.3% | - | 37.2% |
Culture converted before month 2 | 21.3% | 96.0% | 35.8% | 31.8% | 72.0% | 20.6% |
Culture converted before month 6 | 65.8% | 93.9% | 78.1% | 65.9% | 72.0% | 65.5% |
Outcome: cured | 48.5% | 72.7% | 69.5% | 65.2% | 72.0% | 48.0% |
Outcome: treatment complete | 15.4% | 11.1% | 7.3% | 2.3% | 28.0% | 15.6% |
Outcome: lost to follow-up | 16.1% | 7.1% | 11.9% | 9.1% | - | 16.3% |
Outcome: treatment failed | 2.0% | 4.0% | 6.6% | 19.7% | - | 1.8% |
Outcome: death | 17.9% | 5.1% | 4.6% | 3.8% | - | 18.3% |
Relapse | .1% | 1% | 4% | 1.5% | - | - |
Lzd resistant at baseline | 0.1% | - | - | 0.8% | - | 0.1% |
MfxÌýresistant at baseline | 1.5% | 35.4% | 15.9% | 53.8% | - | 0.8% |
LfxÌýresistant at baseline | 1.5% | 73.7% | - | 78.8% | - | 0.4% |
OfxÌýresistant at baseline | 2.0% | 22.2% | 88.7% | 34.8% | - | 0.8% |
CfxÌýresistant at baseline | - | - | - | 1.5% | - | - |
BdqÌýresistant at baseline | 0.2% | - | 0.7% | 1.5% | - | 0.1% |
*percentages relative to total number of observations per dataset;
Original Data Curator: Prof Greg Fox, The University of Sydney, AustraliaÌý
Datasets
Please note there is a traffic light system for the datasets.
Green: Available
Yellow: In process
Red: Unavailable
White: In negotiation
Ìý